vs
Side-by-side financial comparison of BT Brands, Inc. (BTBD) and Prelude Therapeutics Inc (PRLD). Click either name above to swap in a different company.
Prelude Therapeutics Inc is the larger business by last-quarter revenue ($6.5M vs $3.9M, roughly 1.7× BT Brands, Inc.). BT Brands, Inc. runs the higher net margin — 23.7% vs -303.5%, a 327.2% gap on every dollar of revenue. On growth, Prelude Therapeutics Inc posted the faster year-over-year revenue change (116.7% vs -11.4%).
BT Brands, Inc.BTBDEarnings & Financial Report
BT Group plc is a British multinational telecommunications holding company headquartered in London, England. It has operations in around 180 countries and is the largest provider of fixed-line, broadband and mobile services in the UK, and also provides subscription television and IT services.
BTBD vs PRLD — Head-to-Head
Income Statement — Q3 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $3.9M | $6.5M |
| Net Profit | $915.0K | $-19.7M |
| Gross Margin | — | — |
| Operating Margin | 19.1% | -314.1% |
| Net Margin | 23.7% | -303.5% |
| Revenue YoY | -11.4% | 116.7% |
| Net Profit YoY | 516.9% | 38.9% |
| EPS (diluted) | $0.15 | $-0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $3.9M | $6.5M | ||
| Q2 25 | $3.8M | — | ||
| Q1 25 | $3.2M | — | ||
| Q3 24 | $4.3M | $3.0M | ||
| Q2 24 | $4.1M | — | ||
| Q1 24 | $3.2M | — | ||
| Q4 23 | $4.0M | — | ||
| Q3 23 | $4.0M | — |
| Q3 25 | $915.0K | $-19.7M | ||
| Q2 25 | $55.0K | — | ||
| Q1 25 | $-329.8K | — | ||
| Q3 24 | $-219.5K | $-32.3M | ||
| Q2 24 | $-70.0K | — | ||
| Q1 24 | $-445.7K | — | ||
| Q4 23 | $-3.5K | — | ||
| Q3 23 | $-233.7K | — |
| Q3 25 | 19.1% | -314.1% | ||
| Q2 25 | -2.0% | — | ||
| Q1 25 | -9.0% | — | ||
| Q3 24 | -1.7% | -1145.9% | ||
| Q2 24 | -4.6% | — | ||
| Q1 24 | -19.8% | — | ||
| Q4 23 | 1.0% | — | ||
| Q3 23 | -2.0% | — |
| Q3 25 | 23.7% | -303.5% | ||
| Q2 25 | 1.5% | — | ||
| Q1 25 | -10.2% | — | ||
| Q3 24 | -5.0% | -1075.7% | ||
| Q2 24 | -1.7% | — | ||
| Q1 24 | -14.0% | — | ||
| Q4 23 | -0.1% | — | ||
| Q3 23 | -5.8% | — |
| Q3 25 | $0.15 | $-0.26 | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | $-0.04 | $-0.43 | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.5M | $55.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $7.7M | $58.5M |
| Total Assets | $11.9M | $94.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $3.5M | $55.0M | ||
| Q2 25 | $3.0M | — | ||
| Q1 25 | $2.7M | — | ||
| Q3 24 | $2.0M | $153.6M | ||
| Q2 24 | $1.5M | — | ||
| Q1 24 | $1.5M | — | ||
| Q4 23 | $1.4M | — | ||
| Q3 23 | $1.2M | — |
| Q3 25 | $7.7M | $58.5M | ||
| Q2 25 | $6.8M | — | ||
| Q1 25 | $6.7M | — | ||
| Q3 24 | $8.5M | $156.4M | ||
| Q2 24 | $8.7M | — | ||
| Q1 24 | $8.8M | — | ||
| Q4 23 | $9.6M | — | ||
| Q3 23 | $9.6M | — |
| Q3 25 | $11.9M | $94.8M | ||
| Q2 25 | $11.2M | — | ||
| Q1 25 | $11.0M | — | ||
| Q3 24 | $13.7M | $197.2M | ||
| Q2 24 | $14.0M | — | ||
| Q1 24 | $14.0M | — | ||
| Q4 23 | $14.9M | — | ||
| Q3 23 | $15.1M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $325.2K | $-19.1M |
| Free Cash FlowOCF − Capex | $261.8K | — |
| FCF MarginFCF / Revenue | 6.8% | — |
| Capex IntensityCapex / Revenue | 1.6% | 0.0% |
| Cash ConversionOCF / Net Profit | 0.36× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $325.2K | $-19.1M | ||
| Q2 25 | $384.4K | — | ||
| Q1 25 | $-306.7K | — | ||
| Q3 24 | $129.3K | $-27.3M | ||
| Q2 24 | $82.5K | — | ||
| Q1 24 | $-408.9K | — | ||
| Q4 23 | $37.0K | — | ||
| Q3 23 | $362.5K | — |
| Q3 25 | $261.8K | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $-431.1K | — | ||
| Q3 24 | $50.4K | $-27.4M | ||
| Q2 24 | $53.7K | — | ||
| Q1 24 | $-521.3K | — | ||
| Q4 23 | $-59.5K | — | ||
| Q3 23 | $203.8K | — |
| Q3 25 | 6.8% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -13.3% | — | ||
| Q3 24 | 1.2% | -912.0% | ||
| Q2 24 | 1.3% | — | ||
| Q1 24 | -16.3% | — | ||
| Q4 23 | -1.5% | — | ||
| Q3 23 | 5.1% | — |
| Q3 25 | 1.6% | 0.0% | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 3.8% | — | ||
| Q3 24 | 1.8% | 2.1% | ||
| Q2 24 | 0.7% | — | ||
| Q1 24 | 3.5% | — | ||
| Q4 23 | 2.4% | — | ||
| Q3 23 | 4.0% | — |
| Q3 25 | 0.36× | — | ||
| Q2 25 | 6.98× | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
